Integrative compositional analyses reveal alterations in microbiota and inflammation between cases and controls
We compared the vaginal microbiota of women who acquired HIV during follow-up (cases) and age and site matched controls using samples collected at the visit prior to seroconversion (or equivalent time point for controls). Cases were fairly evenly distributed across all five CSTs, except no seroconversion occurred among women with CST I-B, which is numerically dominated by Counts and percentages of cases and controls by vaginal community state type